Aptorum Group Enters into an Agreement with Exeltis to Develop Aptorum's Novel Preclinical Candidate Targeting Woman's Gynecological Conditions

Stock Information for Aptorum Group Limited

Loading

Please wait while we load your information from QuoteMedia.